Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1616 1619
This examiner grants 38% of resolved cases
Sarah Alawadi has 680 resolved cases in Tech Center 1600. The allowance rate is 37.5% and the interview lift is 38.4%. The median days to allowance is 1334. In Art Unit 1616, the 37.5% allowance rate indicates a challenging prosecution environment. However, the 38.4% interview lift is very high, suggesting that interviews are a vital tool for success. The 1334-day median reflects a longer prosecution timeline. The 680 resolved cases provide a solid foundation for these metrics.
The 38.4% interview lift is the most prominent feature of this profile. The 37.5% allowance rate is based on 680 cases. The 1334-day median is a critical planning figure for Art Unit 1616. Practitioners should prioritize interviews to overcome the lower allowance rate. These figures highlight the importance of direct communication in Tech Center 1600. The 38.4% lift is a key strategic insight.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18881183 | Pharmaceutical composition and method for enhancing solubility of poorly soluble active pharmaceutical ingredients | Non-Final OA | MERCK PATENT GMBH |
| 18015159 | SILVER ENHANCED CANNABINOID ANTIBIOTICS | Non-Final OA | The University of British Columbia |
| 18864287 | GLP1 TABLET COMPOSITIONS | Non-Final OA | Eli Lilly and Company |
| 18252600 | MARINE COATING COMPOSITION | Non-Final OA | BAE SYSTEMS plc |
| 17933148 | ANTI-C5 ANTIBODIES AND USES THEREOF | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18554917 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | Final Rejection | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 19289461 | SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS | Final Rejection | DSM IP ASSETS B.V. |
| 18266903 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING THIS COMPOSITION | Non-Final OA | L'Oreal |
| 18258066 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | Non-Final OA | L’OREAL |
| 18559940 | SKIN CARE COMPOSITION CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE AND ALKYLENE OXIDE DERIVATIVE | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18580223 | COSMETIC PRODUCT OF PACKAGING AND A PREPARATION CONTAINING 1,2-PROPANE DIOL ESTER | Non-Final OA | BEIERSDORF AG |
| 18492486 | Hair Perming Compositions With Amine Derivatives | Final Rejection | ELC Management LLC |
| 18286492 | CLEANSING COMPOSITION FOR FEMALE INTIMATE HYGIENE | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18011655 | SANITIZING COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18784266 | ANTIMICROBIAL MIXTURES COMPRISING AT LEAST ONE HYDROXYPHENONE DERIVATIVE | Non-Final OA | SYMRISE AG |
| 18045575 | TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME | Final Rejection | INOVIO PHARMACEUTICALS, INC. |
| 18006744 | Anti-Microbial Compositions | Non-Final OA | 5D HEALTH PROTECTION GROUP LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy